Sunday, 16 June 2013

Harvard researchers isolate stem cells from patients with Pearson Marrow Pancreatic Syndrome

Using a difficult laboratory technique, Harvard Stem Cell Institute (HSCI) physician-researchers have isolated genetically healthy stem cells from patients with Pearson Marrow Pancreas Syndrome (PS), a generally fatal infant blood disorder with less than a hundred reported cases worldwide. Children with PS experience a range of symptoms, most notably: anaemia, decreased organ function, and difficulty absorbing nutrients and gaining weight. Blood transfusions can prolong life, but once diagnosed, a PS patient isn’t expected to make it past his or her fifth birthday.

HSCI Principal Faculty member Suneet Agarwal, MD, PhD, at Boston Children’s Hospital, is one of only a few physicians in the United States actively researching rare blood disorders like PS.

“At Children’s, I get exposed to these diseases because of our referrals from around the country and around the world to care for these patients,” he said.

Pearson Marrow Pancreas Syndrome is caused by a deletion of a specific region of a person’s mitochondrial DNA. In addition to a complete set of parental chromosomes, all human cells carry additional genes in their mitochondria, mostly dedicated to energy production. In PS, varying levels of mutant mitochondrial DNA in different cells determines the severity of symptoms for individuals with the disease, leading to a diagnosis with no sure prognosis.

Dr. Suneet Agarwal talks about his work as a pediatric oncologist at Dana-Farber/Children's Hospital Cancer Center (DF/CHCC).

Curious to learn more about PS at the molecular level, Agarwal’s lab, in collaboration with HSCI Executive Committee member George Daley, MD, PhD, reprogrammed cells from patients into induced pluripotent stem cells.

Despite technical challenges and due to the mixture of affected mitochondria found in patients, Agarwal was able to isolate stem cells that had no mutant mitochondrial DNA.
“While making these manipulations, all of a sudden, in our hands is something genetically identical to the patient, a living cell, that doesn’t have the defect anymore, so it essentially corrected itself.” said Suneet Agarwal.

With the support of a 2013 HSCI Seed Grant, Agarwal plans to investigate whether his technical achievement can translate into patient therapies.

Cherry, A., Gagne, K., McLoughlin, E., Baccei, A., Gorman, B., Hartung, O., Miller, J., Zhang, J., Zon, R., Ince, T., Neufeld, E., Lerou, P., Fleming, M., Daley, G., & Agarwal, S. (2013). Induced Pluripotent Stem Cells with a Pathological Mitochondrial DNA Deletion STEM CELLS DOI: 10.1002/stem.1354

No comments:

Post a Comment

Please note that we dont offer any kind of medical advice. Questions requesting specific medical advice (e.g. where can I get this treatment, will this cure XXX condition, etc) will be published but most probably ignored by the administrators. :)

Note to spammers: You shall not pass. If you really want a link from us then consider making a stem cell related guest post !